The design and synthesis of novel orally active inhibitors of AP-1 and NF-kappaB mediated transcriptional activation. SAR of in vitro and in vivo studies.

Citation: Palanki MS, Erdman PE, Ren M, Suto M, Bennett BL, Manning A, Ransone L, Spooner C, Desai S, Ow A, Totsuka R, Tsao P, Toriumi W.: The design and synthesis of novel orally active inhibitors of AP-1 and NF-kappaB mediated transcriptional activation. SAR of in vitro and in vivo studies. Bioorg Med Chem Lett, Volume 13 (22), 2003
Authors: Bennett BL, Desai S, Erdman PE, Manning A, Ow A, Palanki MS, Ransone L, Ren M, Spooner C, Suto M, Toriumi W., Totsuka R, Tsao P
Journal: Bioorg Med Chem Lett
Year: 2003
DOI: 10.1016/j.bmcl.2003.08.047
PubMed: 14592511
Machine-readable: REST API RDF

Publication